15-51683369-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_013243.4(SCG3):āc.332C>Gā(p.Thr111Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000134 in 1,613,632 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 32)
Exomes š: 0.00013 ( 0 hom. )
Consequence
SCG3
NM_013243.4 missense
NM_013243.4 missense
Scores
5
5
9
Clinical Significance
Conservation
PhyloP100: 7.04
Genes affected
SCG3 (HGNC:13707): (secretogranin III) The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. Granins may serve as precursors for biologically active peptides. Some granins have been shown to function as helper proteins in sorting and proteolytic processing of prohormones; however, the function of this protein is unknown. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCG3 | NM_013243.4 | c.332C>G | p.Thr111Ser | missense_variant | 4/12 | ENST00000220478.8 | NP_037375.2 | |
SCG3 | NM_001165257.2 | c.-365C>G | 5_prime_UTR_variant | 3/11 | NP_001158729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCG3 | ENST00000220478.8 | c.332C>G | p.Thr111Ser | missense_variant | 4/12 | 1 | NM_013243.4 | ENSP00000220478.3 | ||
SCG3 | ENST00000542355.6 | c.-365C>G | 5_prime_UTR_variant | 3/11 | 2 | ENSP00000445205.2 | ||||
SCG3 | ENST00000558709.1 | c.-222C>G | 5_prime_UTR_variant | 3/5 | 2 | ENSP00000452745.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152110Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
22
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251162Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135796
GnomAD3 exomes
AF:
AC:
43
AN:
251162
Hom.:
AF XY:
AC XY:
22
AN XY:
135796
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461404Hom.: 0 Cov.: 30 AF XY: 0.000135 AC XY: 98AN XY: 727044
GnomAD4 exome
AF:
AC:
194
AN:
1461404
Hom.:
Cov.:
30
AF XY:
AC XY:
98
AN XY:
727044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000145 AC: 22AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74418
GnomAD4 genome
AF:
AC:
22
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
16
Asia WGS
AF:
AC:
1
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2024 | The c.332C>G (p.T111S) alteration is located in exon 4 (coding exon 4) of the SCG3 gene. This alteration results from a C to G substitution at nucleotide position 332, causing the threonine (T) at amino acid position 111 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of phosphorylation at S110 (P = 0.12);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at